Stay updated with breaking news from Exscientia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exscientia (Nasdaq: EXAI) today announced that Ben Taylor, CFO Chief Strategy Officer and Garry Pairaudeau, Chief Technology Officer, will participate in a fireside chat at the BofA Securities 2022 Healthcare
Exscientia (NASDAQ:EXAI – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Zacks.com reports. The brokerage presently has a $14.00 price objective on the stock. Zacks Investment Research‘s price target would suggest a potential downside of 7.16% from the […]
Exscientia plc (Nasdaq: EXAI) today shared details of its participation at the upcoming American Association for Cancer Research (AACR) Annual Meeting, taking place April 8-13 2022 at the Ernest N. Morial
Exscientia plc (Nasdaq: EXAI) today announced the appointment of Michael Krams, M.D., as its Chief Quantitative Medicine Officer. In this newly created role, Dr. Krams will lead clinical development
Shares of Exscientia Ltd (NASDAQ:EXAI – Get Rating) gapped up prior to trading on Tuesday . The stock had previously closed at $13.51, but opened at $14.25. Exscientia shares last traded at $14.50, with a volume of 545 shares. Separately, Zacks Investment Research cut shares of Exscientia from a “buy” rating to a “hold” rating […]